ssMutPA: A New Method for Analyzing Cancer Pathways Using Mutation Data
Author Information
Author(s): He Yalan, Lai Jiyin, Wang Qian, Pan Bingyue, Li Siyuan, Zhao Xilong, Wang Ziyi, Zhang Yongbao, Tang Yujie, Han Junwei
Primary Institution: College of Bioinformatics Science and Technology, Harbin Medical University
Hypothesis
Can a novel single-sample mutation-based pathway analysis approach (ssMutPA) improve the identification of cancer subtypes and biomarkers for precision medicine?
Conclusion
The ssMutPA method effectively infers mutation-based individualized pathway activity profiles, revealing significant prognostic differences across cancer types.
Supporting Evidence
- ssMutPA was applied to 33 cancer cohorts from The Cancer Genome Atlas database.
- Patients were stratified into subtypes with significantly different prognoses based on ssMutPES profiles.
- Identified pathways showed high overlap across different cancers and could serve as potential prognostic biomarkers.
- ssMutPA was validated in independent glioma datasets, demonstrating robustness and generalizability.
Takeaway
This study introduces a new way to look at cancer by using mutation data to understand how pathways in cells are affected, which can help doctors make better treatment decisions.
Methodology
The ssMutPA method integrates somatic mutation data with protein–protein interaction networks to calculate mutation-based pathway enrichment scores for individual cancer samples.
Limitations
The method may be limited by the completeness of the protein-protein interaction network used.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website